Skip to main content
    P

    Progyny Inc (PGNY)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NASDAQ

    $36.18
    -0.40 (-1.09%)

    Market Cap: $2.66B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Progyny Inc (PGNY) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Progyny (PGNY) trades at 28.0x trailing earnings and 2.1x sales. Its P/E of 28.0x is below its 5-year median of 35.5x. Its forward P/E is 15.2x. The median P/E across 10 similar companies is 48.0x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 84.2% higher over the next year. Its free cash flow yield is 6.5%.

    MultipleValue
    P/E (trailing)28.0x
    Forward P/E15.2x
    Price to sales2.1x
    Price to book6.7x
    EV/EBITDA19.0x
    Price to FCF15.4x
    EV/FCF14.7x
    PEGN/A
    FCF yield6.5%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/E28.0x35.5xN/A
    P/S2.1x2.6xN/A
    P/B6.7x5.8xN/A
    Medians of month-end values through Oct 2026: 60 months (5-year).

    Valuation History

    Over the 6 of the 7 year ends shown that have a P/E, its P/E ranged from 10.5x in 2024 to 353.3x in 2020.

    Year endPriceP/EP/SP/B
    2025$25.6820.4x1.7x4.5x
    2024$17.2510.5x1.4x3.9x
    2023$37.1860.0x3.3x6.8x
    2022$31.15103.8x3.7x8.3x
    2021$50.3576.3x9.2x20.1x
    2020$42.39353.3x10.9x25.1x
    2019$27.45N/A2.6x15.4x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PGNY

    What is PGNY's forward P/E ratio?

    Progyny has a forward P/E ratio of 15.2x.

    Is PGNY stock overvalued?

    GNG's valuation label for PGNY is Fairly valued. Its P/E of 28.0x compares with a median of 48.0x across 10 similar companies.

    What is PGNY's price to sales ratio?

    Progyny has a price to sales ratio of 2.1x.

    What is Progyny's average P/E ratio over 5 years?

    Progyny's median P/E over the last 5 years is 35.5x, from 60 month-end values through Oct 2026.